Sudo Biosciences
Menlo Park, CA
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Their lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked... Read more
sudobio.comCompany Details
Founded
- 2020
Employees
- Between 10 - 50 employees
Raised
- $183,000,000
Headquarters Location
- Menlo Park, CA
Public
- No
Acquired
- No
CEO
Scott Byrd
Founders
- Daniel Estes
Company Collections
These are collections Sudo Biosciences is a part of. Click on the collection name to view similar companies.